PlainRecalls
FDA Drug Critical Class I Ongoing

Bupivacaine Hydrochloride Inj., USP (2.5 mg/mL) 0.25%, packaged in 30 mL Single-dose Preservative-Free vials, Rx Only, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-1159-02

Reported: December 28, 2016 Initiated: August 4, 2016 #D-0218-2017

Product Description

Bupivacaine Hydrochloride Inj., USP (2.5 mg/mL) 0.25%, packaged in 30 mL Single-dose Preservative-Free vials, Rx Only, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-1159-02

Reason for Recall

Presence of particulate matter: Confirmed customer report for the presence of particulate matter within a single vial.

Details

Units Affected
143,250 vials
Distribution
Nationwide
Location
Lake Forest, IL

Frequently Asked Questions

What product was recalled?
Bupivacaine Hydrochloride Inj., USP (2.5 mg/mL) 0.25%, packaged in 30 mL Single-dose Preservative-Free vials, Rx Only, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-1159-02. Recalled by Hospira Inc., A Pfizer Company. Units affected: 143,250 vials.
Why was this product recalled?
Presence of particulate matter: Confirmed customer report for the presence of particulate matter within a single vial.
Which agency issued this recall?
This recall was issued by the FDA Drug on December 28, 2016. Severity: Critical. Recall number: D-0218-2017.